BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

BlackRock, Inc.'s Holding History (CIK: 0002012383)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 9,450,000 Value ($000) $10,608 Avg Close Range
Q3 2025
Shares 7,150,000 Value ($000) $7,039 Avg Close Range
Q2 2025
Shares 7,175,000 Value ($000) $6,680 Avg Close Range
Q1 2025
Shares 7,725,000 Value ($000) $6,925 Avg Close Range
Q4 2024
Shares 7,525,000 Value ($000) $6,419 Avg Close Range
Q3 2024
Shares 6,125,000 Value ($000) $5,114 Avg Close Range